These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1831230)

  • 21. Optimum sample times for single-injection, multisample renal clearance methods.
    Russell CD
    J Nucl Med; 1993 Oct; 34(10):1761-5. PubMed ID: 8410295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diuresis renography. A simultaneous comparison between 131I-hippuran and 99Tcm-MAG3.
    Hvid-Jacobsen K; Thomsen HS; Nielsen SL
    Acta Radiol; 1990 Jan; 31(1):83-6. PubMed ID: 2140270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurements of 99mTc-MAG3 uptake in renal transplant recipients.
    Oei HY; Surachno S; Wilmink JM; van der Schoot JB
    Contrib Nephrol; 1990; 79():113-7. PubMed ID: 2146080
    [No Abstract]   [Full Text] [Related]  

  • 24. An investigation of factors that might influence the radiochemical purity and stability of 99mTc-MAG3.
    Millar AM; O'Brien LM
    Eur J Nucl Med; 1990; 16(8-10):615-9. PubMed ID: 2143474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radionuclide renal studies.
    Abdel-Dayem HM; Turoglu HT
    Curr Opin Radiol; 1990 Dec; 2(6):834-43. PubMed ID: 2149277
    [No Abstract]   [Full Text] [Related]  

  • 26. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
    Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
    J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technetium-99m labeled renal function and imaging agents: III. Synthesis of 99mTc-MAG3 and biodistribution of by-products.
    Brandau W; Bubeck B; Eisenhut M; Taylor DM
    Int J Rad Appl Instrum A; 1988; 39(2):121-9. PubMed ID: 2833469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Searching for the ideal kidney agent.
    Britton KE
    Nucl Med Commun; 1986 Mar; 7(3):145-7. PubMed ID: 2940482
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH.
    Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Mourad M; Leners N; Squifflet JP; Beckers C
    J Nucl Med; 1994 Dec; 35(12):1951-8. PubMed ID: 7989976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of technetium-99m-L,L-ethylenedicysteine in patients with chronic renal failure.
    Prvulovich EM; Bomanji JB; Waddington WA; Rudrasingham P; Verbruggen AM; Ell PJ
    J Nucl Med; 1997 May; 38(5):809-14. PubMed ID: 9170451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorbed radiation dose in adults from iodine-131 and iodine-123 orthoiodohippurate and technetium-99m DTPA renography.
    Carlsen O
    J Nucl Med; 1988 Mar; 29(3):400-6. PubMed ID: 3279170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplant renography: 99m-Tc-DTPA versus 99m-Tc-MAG3. A preliminary note.
    Fraile M; Castell J; Buxeda M; Cuartero A; Cantarell C; Domenech-Torné FM
    Eur J Nucl Med; 1989; 15(12):776-9. PubMed ID: 2533892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of technetium-99m-MAG3 plasma clearance in adults from one or two blood samples.
    Russell CD; Taylor A; Eshima D
    J Nucl Med; 1989 Dec; 30(12):1955-9. PubMed ID: 2531219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential Tc 99m mercaptoacetyl-triglycine (MAG3) renography as an evaluator of early renal transplant function.
    Carmody E; Greene A; Brennan P; Donohue J; Carmody M; Keeling F
    Clin Transplant; 1993 Jun; 7(3):245-9. PubMed ID: 10148844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The kidney: imaging with Tc-99m mercaptoacetyltriglycine, a technetium-labeled analog of iodohippurate.
    Russell CD; Thorstad BL; Stutzman ME; Yester MV; Fowler D; Dubovsky EV
    Radiology; 1989 Aug; 172(2):427-30. PubMed ID: 2526350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renographic diagnosis of renovascular hypertension with angiotensin converting enzyme inhibition and furosemide.
    Sfakianakis GN; Bourgoignie JJ
    Am J Hypertens; 1991 Dec; 4(12 Pt 2):706S-710S. PubMed ID: 1837993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tc-99m MAG3 as an alternative to Tc-99m DTPA and I-131 Hippuran for renal transplant evaluation.
    O'Malley JP; Ziessman HA; Chantarapitak N
    Clin Nucl Med; 1993 Jan; 18(1):22-9. PubMed ID: 8422715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technetium-99m MAG3 kit formulation: preliminary results in normal volunteers and patients with renal failure.
    Taylor A; Eshima D; Christian PE; Wooten WW; Hansen L; McElvany K
    J Nucl Med; 1988 May; 29(5):616-22. PubMed ID: 2967353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Procedure guideline for diuretic renography in children. Society of Nuclear Medicine.
    Mandell GA; Cooper JA; Leonard JC; Majd M; Miller JH; Parisi MT; Sfakianakis GN
    J Nucl Med; 1997 Oct; 38(10):1647-50. PubMed ID: 9379208
    [No Abstract]   [Full Text] [Related]  

  • 40. Consensus report on ACE inhibitor renography for detecting renovascular hypertension. Radionuclides in Nephrourology Group. Consensus Group on ACEI Renography.
    Taylor A; Nally J; Aurell M; Blaufox D; Dondi M; Dubovsky E; Fine E; Fommei E; Geyskes G; Granerus G; Kahn D; Morton K; Oei HY; Russell C; Sfakianakis G; Fletcher J
    J Nucl Med; 1996 Nov; 37(11):1876-82. PubMed ID: 8917196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.